Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2
This study has been suspended.
Study NCT00033956   Information provided by MetaPhore Pharmaceuticals
First Received: April 17, 2002   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
IL-2 Induced Hypotension
Additional conditions recognized in this trial
Carcinoma, Renal Cell
Hypotension
More general conditions related to this trial
Adenocarcinoma
Carcinoma
Cardiovascular Diseases
Kidney Diseases
Kidney Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Vascular Diseases
Interventions listed in this trial
M40403
Sponsors listed in this trial
MetaPhore Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services